Geistlich - Indication sheets PIR - Peri-Implant Augmentation - Page 6

Long-term success with the dream-team GBR with the dream-team: Geistlich Bio-Oss ® and Geistlich Bio-Gide ® for outstanding and predictable clinical outcomes Clinically, implant placement and simultaneous GBR with Geistlich Bio-Oss ® and Geistlich Bio-Gide ® perform as well as implant placement into native bone with respect to implant survival and marginal bone height for up to 12–14 years. 1 Additionally, clinical investigations suggest a high predictability for successful esthetic outcomes and good long-term stability (up to 6 years) of the established facial bone wall. 2 A LOT HAPPENED IN 12 YEARS, GEISTLICH BIOMATERIALS GRAFTED RIDGES REMAIN STABLE Candy Crush became most popular game on Facebook, with 46 million average monthly users Youtube was launched Twitter turned 11, which by social media standards makes it one of the veterans 2013 2005 2017 2007 2014 The iPhone was presented by Steve Jobs The iWatch was presented by Apple Literature references 1 Jung RE et al., Clin Oral Implants Res. 2013 Oct;24(10):1065–73. 2 Buser D et al., J Dent Res. 2013 Dec;92(12 Suppl):176S–82S. Contacts > Dr. Paul Stone, Blackhills Referral Clinic, Aberuthven, Perthshire, Scotland; Telephone: +44 1764 664446; e-mail: paul@blackhillsclinic.com; website: www.blackhillsclinic.com > Dr. Christian Ramel, Rennweg 58, CH-8001 Zürich, Switzerland; Telephone: +41 44 212 01 10; e-mail: christian.ramel@zahnaerzte-rennweg.ch; www.zahnaerzte-rennweg.ch > Dr. med. dent. Claude Andreoni, Specialist in Reconstructive Dentistry, WBA in Oral Implantology and Dr. med. dent. Thomas Meier, WBA in Oral Implantology, Weinbergstrasse 160, CH-8006 Zurich, Switzerland; Telephone: +41 44 363 15 16; fax: +41 44 363 15 21; e-mail: andreoni-meier@bluewin.ch > Dr. Jean-Pierre Gardella, 131 avenue du Prado, 13008 Marseille, France; Telephone: +33 (0)4 91 79 20 90; fax: +33 (0)4 91 79 92 49; e-mail: jpgardella@gardellaclinic.com > Prof. Dr. Buser, Department of Oral Surgery and Stomatology, University of Berne, Freiburgstrasse 7, 3010 Berne, Switzerland; Telephone: +41 (0)31 632 25 55; e-mail: daniel.buser@zmk.unibe.ch Further Indication Sheets > To receive these by mail free of charge, please contact: www.geistlich-biomaterials.com > If you do not wish to collect indication sheets any more, please unsubscribe via your local distribution partner. 6 Pre d ther ic t able a impl py + hig ant s h r ate u r v i v a l up t o 12–1 4 ye ars 1